Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
40.01
-0.21 (-0.52%)
At close: Jul 31, 2026, 4:00 PM EDT
40.03
+0.02 (0.05%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Indivior Pharmaceuticals Market Cap
Indivior Pharmaceuticals has a market cap or net worth of $4.88 billion as of July 31, 2026. Its market cap has increased by 124.69% in one year.
Market Cap
4.88B
Enterprise Value
5.21B
1-Year Change
124.69%
Ranking
Category
Stock Price
$40.01
ChartMarket Cap Chart
Since December 29, 2014, Indivior Pharmaceuticals's market cap has increased from $1.53B to $4.88B, an increase of 218.71%. That is a compound annual growth rate of 10.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 4.88B | 8.89% |
| Dec 31, 2025 | 4.48B | 188.39% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 9.97B |
| Alkermes | 8.22B |
| Liquidia | 7.65B |
| Hims & Hers Health | 6.49B |
| Lantheus Holdings | 6.45B |
| Kiniksa Pharmaceuticals International, | 6.13B |
| Amneal Pharmaceuticals | 6.06B |
| Regencell Bioscience Holdings | 2.84B |